Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

April 10, 2018; 90 (15 Supplement) April 23, 2018

Predicting Ambulatory Aid Needs with Disease Progression in Charcot-Marie-Tooth Disease (P2.328)

Sindhu Ramchandren, Jacob Moore, Joseph Hornyak
First published April 9, 2018,
Sindhu Ramchandren
1Neurology, University of Michigan Ann Arbor MI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacob Moore
3PMR, A. T. Still University SOMA Mesa AZ United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Hornyak
2Physical Medicine and Rehabilitation, University of Michigan Ann Arbor MI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
Predicting Ambulatory Aid Needs with Disease Progression in Charcot-Marie-Tooth Disease (P2.328)
Sindhu Ramchandren, Jacob Moore, Joseph Hornyak
Neurology Apr 2018, 90 (15 Supplement) P2.328;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
0

Share

  • Article
  • Info & Disclosures
Loading

Abstract

Objective: To develop predictive scales that correlate Charcot-Marie-Tooth Neuropathy Score version 2 (CMTNSv2) scores with specific ambulatory aid use in pediatric patients with Charcot Marie Tooth disease (CMT).

Background: CMT, the most common genetic neuromuscular disease, causes progressive decline in strength with increased use of ambulatory aids such as orthoses, canes, walkers and wheelchairs as the disease progresses. The CMT neuropathy score (CMTNSv2) is a validated outcome measure that categorizes the severity of neuropathy into mild, moderate or severe neuropathy in patients with CMT. The correlations between CMTNSv2 and ambulatory aid use in children has not been studied.

Design/Methods: Pediatric patients consented through the Inherited Neuropathy Consortium for the natural history clinical registry trial were assessed in this retrospective cross-sectional study. Data collected included demographics, CMTNS, type of ambulatory aid used, foot surgery, difficulty with buttons, and with utensils. Mean scores and standard deviations for the CMTNS were calculated.

Results: Of 625 eligible patients, 539 had completed data and were included in the analysis. Mean age was 13 (range 8–18, SD 2.9); Gender: 270 M, 269 F; Race: 84% Caucasian. Ambulatory aid used correlated strongly with CMTNS score (0.63, p < 0.0001). Smaller correlations were seen between ambulatory aid used and foot surgery (0.16, p =0.007), buttons (0.31, p < 0.0001) and eating utensils (0.33, p < 0.0001). Mean CMTNS for using no aids or minimal aids (shoe inserts, custom shoes, night-splints) were equivalent at 8.4. Mean CMTNS for using supramalleolar orthosis (SMO), supramalleolar ankle foot orthosis (SMAFO), molded/ankle foot orthosis (MAFO/AFO), and Arizona brace were equivalent at 10.5. Mean CMTNS for using wheelchair or scooter was 23.

Conclusions: We have developed predictive scales that correlate specific scores in CMTNS with progressive functional aid needs. We recommend prospective validation of our predictive scales in a CMT population.

Disclosure: Dr. Ramchandren has nothing to disclose. Dr. Moore has nothing to disclose. Dr. Hornyak has nothing to disclose.

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 96 (4)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2021 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise